What is the clinical profile and outcome of Carbapenem-Resistant Acinetobacter baumannii infection?
Carbapenem-Resistant Acinetobacter baumannii infections are associated with high mortality and severe outcomes. Evidence indicates sulbactam-based and cefiderocol regimens as potentially effective treatments. More research is needed to optimize therapeutic strategies and outcomes.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-29
- DOI
- https://doi.org/10.5281/zenodo.23755569
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00